Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Performance of community pharmacy drug interaction software.

T K Hazlet1, T A Lee, P D Hansten

  • 1Department of Pharmacy, School of Pharmacy, University of Washington, Seattle 98195-7630, USA. thazlet@u.washington.edu

Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)
|April 12, 2001
PubMed
Summary

Computerized drug-drug interaction (DDI) software often fails to detect clinically significant interactions, missing one-third of cases. Further improvements are crucial for enhancing patient safety through accurate DDI detection.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of Hydrocodone Rescheduling on Dental Prescribing of Opioids.

JDR clinical and translational research·2022
Same author

Distribution of Isolates of Sclerotium rolfsii Tolerant to Pentachloronitrobenzene in Texas Peanut Fields.

Plant disease·2019
Same author

Inhaled Anticholinergics and Risk for Acute Urinary Retention: A Case-Crossover and Case-Time-Control Study.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2016
Same author

Comparison of Health Care Utilization and Costs for Patietns with Asthma by Severity and Health Insurance in Thailand: Using Generalized Linear Regression Model.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2016
Same author

An evaluation of the potential drug interaction between warfarin and levothyroxine.

Journal of thrombosis and haemostasis : JTH·2014
Same author

Prioritizing comparative-effectiveness research topics via stakeholder involvement: an application in COPD.

Clinical pharmacology and therapeutics·2011

Area of Science:

  • Pharmacology
  • Health Informatics
  • Clinical Pharmacy

Background:

  • Computerized drug-drug interaction (DDI) software is widely used in clinical practice to prevent adverse drug events.
  • The effectiveness of these software systems in identifying clinically significant DDIs requires ongoing evaluation.

Purpose of the Study:

  • To assess the performance of various computerized DDI software programs in detecting important drug-drug interactions.
  • To quantify the accuracy of DDI software using key performance metrics.

Main Methods:

  • A one-time performance test was conducted using a standardized set of prescriptions.
  • Nine different DDI software programs were evaluated across 516 community pharmacies.
  • The study measured sensitivity, specificity, and predictive values for detecting 16 known DDIs in fictitious patient profiles.

Related Experiment Videos

Main Results:

  • The evaluated DDI software failed to detect clinically relevant interactions in approximately one-third of instances.
  • Software sensitivity ranged from 0.44 to 0.88, indicating suboptimal performance in some cases.
  • Variability in performance was observed between different installations of the same software packages.

Conclusions:

  • The performance of most tested DDI-detecting software was suboptimal.
  • Enhancements are necessary to improve the reliability and clinical utility of DDI software.
  • Better DDI detection is essential for improving patient safety and medication management.